A pilot trial of high-dose-rate intraoperative radiation therapy for malignant pleural mesothelioma-Reference-Cited by-同舟云学术

A pilot trial of high-dose-rate intraoperative radiation therapy for malignant pleural mesothelioma

Published:2005-01 Issue:1 Volume:4 Page:30-33
ISSN:1538-4721
Container-title:Brachytherapy
language:en
Short-container-title:Brachytherapy

Author:

Rosenzweig Kenneth E.,Fox Jana L.,Zelefsky Michael J.,Raben Adam,Harrison Louis B.,Rusch Valerie W.

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Reference8 articles.

1. Treatment of intervention sites of malignant pleural mesothelioma with radiotherapy: A Dutch-Belgian survey;De Ruysscher;Radiother Oncol,2003

2. A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma;Rusch;J Thorac Cardiovasc Surg,2001

3. Pleurectomy and intraoperative brachytherapy and postoperative radiation in the treatment of malignant pleural mesothelioma;Hilaris;Int J Radiat Oncol Biol Phys,1984

4. Radical pleurectomy/decortication and intraoperative radiotherapy followed by conformal radiation with or without chemotherapy for malignant pleural mesothelioma;Lee;J Thorac Cardiovasc Surg,2002

5. Results of treatment of malignant pleural mesothelioma with surgery, brachytherapy, and external beam irradiation;Mychalczak;Endocurie Hypertherm Oncol,1989

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intraoperative radiation and electronic brachytherapy in Brachytherapy: A look back and forward;Brachytherapy;2023-01

2. Recommendations for intraoperative mesh brachytherapy: Report of AAPM Task Group No. 222;Medical Physics;2021-09-02

3. The Role of Adjuvant Radiotherapy in the Treatment of Pleural Mesothelioma;Annals of Surgical Oncology;2019-02-24

4. A Phase I Trial of Surgical Resection and Intraoperative Hyperthermic Cisplatin and Gemcitabine for Pleural Mesothelioma;Journal of Thoracic Oncology;2018-09

5. Radiotherapy for the treatment of malignant pleural mesothelioma;The Lancet Oncology;2017-09